#covidvaccine #covidshield #sideeffects
A significant update has emerged regarding the COVID vaccine and its rare side effects, sparking concerns among health experts. AstraZeneca, a British-Swedish pharmaceutical giant, has admitted in court papers that its COVID vaccine, Covishield, can cause rare adverse reactions
, as reported by The Telegraph. Covishield, developed by AstraZeneca and produced by the Serum Institute of India, is under scrutiny as the company faces a class action lawsuit in the UK over allegations of vaccine-related deaths, with 51 cases filed against it. AstraZeneca's admission in court papers includes the acknowledgment that Covishield can, in very rare cases, lead to Thrombosis with Thrombocytopenia Syndrome (TTS), a serious condition characterized by blood clot formation coupled with low platelet counts.
Check full updates on Medical Dialogues
Also check out -
Medical Dialogues Academy, a renowned academic wing of Medical Dialogues - India's premier health and news online portal, proudly presents this comprehensive course tailored for healthcare professionals eager to delve into the realm of medical journalism.
🔗 Enroll Today: [ Ссылка ]
📚 Explore More With Us:
📌 Medical Content Writing: [ Ссылка ]
📌 Certificate Course in Pharmaceutical Medico-Marketing: [ Ссылка ]
Join us on this enlightening journey and become a part of a community pushing the boundaries of healthcare communication and reporting.
Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Website: [ Ссылка ]
![](https://i.ytimg.com/vi/gaiGB3k-P7c/maxresdefault.jpg)